These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 27547932)

  • 1. [Comparative Cost Effectiveness of Clostridium Histolyticum Collagenase (Xiapex®) and Partial Fasciectomy for the Treatment of Dupuytren's Contracture in Austria].
    Neuwirth M; Binter A; Pipam W; Rab M
    Handchir Mikrochir Plast Chir; 2016 Aug; 48(4):233-8. PubMed ID: 27547932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost Comparison of Collagenase Clostridium Histolyticum and Fasciectomy for Treatment of Dupuytren's Contracture in the Australian Health System.
    Sefton AK; Smith BJ; Stewart DA
    J Hand Surg Asian Pac Vol; 2018 Sep; 23(3):336-341. PubMed ID: 30282551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness in the management of Dupuytren's contracture. A Canadian cost-utility analysis of current and future management strategies.
    Baltzer H; Binhammer PA
    Bone Joint J; 2013 Aug; 95-B(8):1094-100. PubMed ID: 23908426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dupuytren's Contracture Recurrence and Treatment Following Collagenase Clostridium Histolyticum Injection: A Longitudinal Assessment in a Veteran Population.
    Zarb RM; Graf AR; Talhelm JE; Stehr RC; Sanger JR; Matloub HS; Daley RA
    Mil Med; 2023 Aug; 188(9-10):e2975-e2981. PubMed ID: 36928340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DupuytrEn Treatment EffeCtiveness Trial (DETECT): a protocol for prospective, randomised, controlled, outcome assessor-blinded, three-armed parallel 1:1:1, multicentre trial comparing the effectiveness and cost of collagenase clostridium histolyticum, percutaneous needle fasciotomy and limited fasciectomy as short-term and long-term treatment strategies in Dupuytren's contracture.
    Räisänen MP; Karjalainen T; Göransson H; Reito A; Kautiainen H; Malmivaara A; Leppänen OV
    BMJ Open; 2018 Mar; 8(3):e019054. PubMed ID: 29599391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Range of motion, postoperative rehabilitation and patient satisfaction in MCP and PIP joints affected by Dupuytren Tubiana stage 1-3: collagenase enzymatic fasciotomy or limited fasciectomy? A clinical study in 52 patients.
    Leclère FM; Kohl S; Varonier C; Unglaub F; Vögelin E
    Arch Orthop Trauma Surg; 2018 Nov; 138(11):1623-1631. PubMed ID: 30259125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collagenase clostridium histolyticum for the treatment of Dupuytren's contracture: systematic review and economic evaluation.
    Brazzelli M; Cruickshank M; Tassie E; McNamee P; Robertson C; Elders A; Fraser C; Hernandez R; Lawrie D; Ramsay C
    Health Technol Assess; 2015 Oct; 19(90):1-202. PubMed ID: 26524616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of resources and costs associated with the treatment of Dupuytren's contracture at an orthopedics and traumatology surgery department in Denia (Spain): collagenase clostridium hystolyticum versus subtotal fasciectomy.
    Sanjuan Cerveró R; Franco Ferrando N; Poquet Jornet J
    BMC Musculoskelet Disord; 2013 Oct; 14():293. PubMed ID: 24125161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single-centre cost comparison analysis of collagenase injection versus surgical fasciectomy for Dupuytren's contracture of the hand.
    Mehta S; Belcher HJ
    J Plast Reconstr Aesthet Surg; 2014 Mar; 67(3):368-72. PubMed ID: 24486152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacies and limitations of fasciectomy and collagenase clostridium histolyticum in Dupuytren's contracture management: A meta-analysis.
    Cooper TB; Poonit K; Yao C; Jin Z; Zheng J; Yan H
    J Orthop Surg (Hong Kong); 2020; 28(2):2309499020921747. PubMed ID: 32484064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Budget impact analysis in Spanish patients with Dupuytren's contracture: fasciectomy vs. collagenase Clostridium histolyticum.
    De Salas-Cansado M; Cuadros M; Del Cerro M; Arandes JM
    Chir Main; 2013 Apr; 32(2):68-73. PubMed ID: 23507313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and tolerability of collagenase Clostridium histolyticum and fasciectomy for Dupuytren's contracture.
    Peimer CA; Wilbrand S; Gerber RA; Chapman D; Szczypa PP
    J Hand Surg Eur Vol; 2015 Feb; 40(2):141-9. PubMed ID: 24698851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the better treatment for single digit dupuytren's contracture: surgical release or collagenase clostridium histolyticum (Xiapex) injection?
    Povlsen B; Povlsen SD
    Hand Surg; 2014; 19(3):389-92. PubMed ID: 25155703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collagenase Clostridium Histolyticum versus Limited Fasciectomy for Dupuytren's Contracture: Outcomes from a Multicenter Propensity Score Matched Study.
    Zhou C; Hovius SER; Slijper HP; Feitz R; Van Nieuwenhoven CA; Pieters AJ; Selles RW
    Plast Reconstr Surg; 2015 Jul; 136(1):87-97. PubMed ID: 25829153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dupuytren's interventions surgery versus collagenase (DISC) trial: study protocol for a pragmatic, two-arm parallel-group, non-inferiority randomised controlled trial.
    Dias J; Arundel C; Tharmanathan P; Keding A; Welch C; Corbacho B; Armaou M; Leighton P; Bainbridge C; Craigen M; Flett L; Gascoyne S; Hewitt C; James E; James S; Johnson N; Jones J; Knowlson C; Radia P; Torgerson D; Warwick D; Watson M
    Trials; 2021 Sep; 22(1):671. PubMed ID: 34593024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between Collagenase Injection and Partial Fasciectomy in the Treatment of Dupuytren's Contracture.
    Tay TK; Tien H; Lim EY
    Hand Surg; 2015 Oct; 20(3):386-90. PubMed ID: 26387998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collagenase clostridium histolyticum in Dupuytren's contracture: a systematic review.
    Smeraglia F; Del Buono A; Maffulli N
    Br Med Bull; 2016 Jun; 118(1):149-58. PubMed ID: 27151958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dupuytren Contracture Recurrence Following Treatment With Collagenase Clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-Year Data.
    Peimer CA; Blazar P; Coleman S; Kaplan FT; Smith T; Lindau T
    J Hand Surg Am; 2015 Aug; 40(8):1597-605. PubMed ID: 26096221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term experience with Collagenase Clostridium Histolyticum (CCH, Xiapex®) for the treatment of Dupuytren's contracture: lessons learned].
    Neuwirth M; Kalt L; Pipam W; Rab M
    Handchir Mikrochir Plast Chir; 2019 Feb; 51(1):38-44. PubMed ID: 30836418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injectable Collagenase Versus Percutaneous Needle Fasciotomy for Dupuytren Contracture in Proximal Interphalangeal Joints: A Randomized Controlled Trial.
    Skov ST; Bisgaard T; Søndergaard P; Lange J
    J Hand Surg Am; 2017 May; 42(5):321-328.e3. PubMed ID: 28473158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.